The clinicopathological characteristics, prognosis and immune microenvironment mapping in MSI-H/MMR-D endometrial carcinomas

Endometrial cancer had a relatively high prevalence of MMR deficiency. MMR-D/MSI-H endometrial cancer patients are suggested to be potential beneficiaries of PD-1/PD-L1 inhibitor therapy. Here, we explored the prognostic value of MSI subtype in endometrial cancer and its correlation with immune envi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yu-e, Liu, Yin, Zhang, Wei, Luo, Heng, Shu, Ping, Chen, Guofang, Li, Yuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894509/
https://www.ncbi.nlm.nih.gov/pubmed/35239036
http://dx.doi.org/10.1007/s12672-022-00466-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894509/
https://www.ncbi.nlm.nih.gov/pubmed/35239036
http://dx.doi.org/10.1007/s12672-022-00466-5

Ejemplares similares